The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
Authors
Keywords
Chronic Kidney Disease, Erectile Dysfunction, Losartan, Serum Uric Acid, Valsartan
Journal
American Journal of Cardiovascular Drugs
Volume 16, Issue 4, Pages 255-266
Publisher
Springer Nature
Online
2016-03-03
DOI
10.1007/s40256-016-0165-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of hypertension in patients with coronary artery disease
- (2015) Clive Rosendorff et al. Journal of the American Society of Hypertension
- Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
- (2015) Suetonia C Palmer et al. LANCET
- Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial
- (2015) Wen-Wei Qi et al. Trials
- Effect of an angiotensin II receptor blocker and a calcium channel blocker on hypertension associated penile dysfunction in a rat model
- (2014) Shogo SHIMIZU et al. BIOMEDICAL RESEARCH-TOKYO
- Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study
- (2014) Chia-Hsuin Chang et al. Cardiovascular Diabetology
- Comparative Effectiveness of Olmesartan and Other Angiotensin Receptor Blockers in Diabetes Mellitus
- (2014) Raj Padwal et al. HYPERTENSION
- Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk
- (2014) Sébastien Foulquier et al. JOURNAL OF HYPERTENSION
- Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer’s disease model
- (2014) Brice Ongali et al. NEUROBIOLOGY OF DISEASE
- Telmisartan attenuates cognitive impairment caused by chronic stress in rats
- (2014) Dominik Wincewicz et al. Pharmacological Reports
- Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study)
- (2013) Jeong Bae Park et al. American Journal of Cardiovascular Drugs
- Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study
- (2013) T. Antoniou et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Combined Antihypertensive Therapy and Sexual Dysfunction: Terra Incognita
- (2013) M. Doumas et al. CARDIOLOGY
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Telmisartan as a metabolic sartan: The first meta-analysis of randomized controlled trials in metabolic syndrome
- (2013) Hisato Takagi et al. Journal of the American Society of Hypertension
- A review of the positive and negative effects of cardiovascular drugs on sexual function: a proposed table for use in clinical practice
- (2013) M. P. J. Nicolai et al. Netherlands Heart Journal
- Irbesartan promotes erection recovery after nerve-sparing radical retropubic prostatectomy: a retrospective long-term analysis
- (2012) Robert L. Segal et al. BJU INTERNATIONAL
- Effect of Telmisartan on Paroxysmal Atrial Fibrillation Recurrence in Hypertensive Patients With Normal or Increased Left Atrial Size
- (2012) Roberto Fogari et al. CLINICAL CARDIOLOGY
- Efficacy and safety of valsartan in reducing blood pressure and albuminuria in Chinese patients with essential hypertension: a multicenter prospective open-label observational study
- (2012) Xiaoyan Zhang et al. CURRENT MEDICAL RESEARCH AND OPINION
- The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO)
- (2012) Kazutoshi Murakami et al. Diabetes & Vascular Disease Research
- Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms
- (2012) N. J. van der Zijl et al. DIABETES OBESITY & METABOLISM
- Effects of valsartan on progression of kidney disease in Japanese hypertensive patients with advanced, predialysis, chronic kidney disease: Kanagawa Valsartan Trial (KVT)
- (2012) Takashi Yasuda et al. HYPERTENSION RESEARCH
- Effects of telmisartan on proteinuria or albuminuria: A meta-analysis of randomized trials
- (2012) Hisato Takagi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Losartan improves erectile dysfunction in diabetic patients: a clinical trial
- (2012) Y Chen et al. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
- Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor/tropomyosin-related kinase B in hippocampus of hypertensive rats
- (2012) Takuya Kishi et al. Journal of Cardiology
- Valsartan Improves Adipose Tissue Function in Humans with Impaired Glucose Metabolism: A Randomized Placebo-Controlled Double-Blind Trial
- (2012) Gijs H. Goossens et al. PLoS One
- Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB Trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE)
- (2011) Yutaka Mori et al. ADVANCES IN THERAPY
- Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials
- (2011) G. Tocci et al. AMERICAN JOURNAL OF HYPERTENSION
- Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats
- (2011) M. Zhao et al. DIABETES OBESITY & METABOLISM
- Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
- (2011) E. Imai et al. DIABETOLOGIA
- Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease
- (2011) Kazumasa Kume et al. Geriatrics & Gerontology International
- Effect of Telmisartan and Ramipril on Atrial Fibrillation Recurrence and Severity in Hypertensive Patients With Metabolic Syndrome and Recurrent Symptomatic Paroxysmal and Persistent Atrial Fibrillation
- (2011) Roberto Fogari et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes
- (2011) N. Suksomboon et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Irbesartan in Patients with Atrial Fibrillation
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- The renin–angiotensin–aldosterone system and glucose homeostasis
- (2011) James Matthew Luther et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Blockade of AT1 Receptors Protects the Blood-Brain Barrier and Improves Cognition in Dahl Salt-Sensitive Hypertensive Rats
- (2010) N. Pelisch et al. AMERICAN JOURNAL OF HYPERTENSION
- Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both
- (2010) Michael Böhm et al. CIRCULATION
- Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension
- (2010) Ulrich Kintscher et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Comparative Effects of Telmisartan and Eprosartan on Insulin Sensitivity in the Treatment of Overweight Hypertensive Patients
- (2009) R. Fogari et al. HORMONE AND METABOLIC RESEARCH
- Next generation multifunctional angiotensin receptor blockers
- (2009) Theodore W Kurtz et al. HYPERTENSION RESEARCH
- Comparative Evaluation of Effect of Valsartan/Amlodipine and Atenolol/Amlodipine Combinations on Atrial Fibrillation Recurrence in Hypertensive Patients With Type 2 Diabetes Mellitus
- (2009) Roberto Fogari et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial
- (2009) Roland E Schmieder et al. JOURNAL OF HYPERTENSION
- Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study
- (2009) Olivier Hanon et al. JOURNAL OF HYPERTENSION
- Preventing stroke: the PRoFESS, ONTARGET, and TRANSCEND trial programs
- (2009) Hans-Christoph Diener JOURNAL OF HYPERTENSION
- Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
- (2009) Marvin A Konstam et al. LANCET
- Valsartan for Prevention of Recurrent Atrial Fibrillation
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Valsartan and Ramipril on Atrial Fibrillation Recurrence and P-wave dispersion in Hypertensive Patients With Recurrent Symptomatic Lone Atrial Fibrillation
- (2008) R. Fogari et al. AMERICAN JOURNAL OF HYPERTENSION
- Rate of MMSE score change in Alzheimer's disease: Influence of education and vascular risk factors
- (2008) Francesco Roselli et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome
- (2008) M Baumhäkel et al. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
- Improvement of Endothelial Function of the Corpus Cavernosum in Apolipoprotein E Knockout Mice Treated with Irbesartan
- (2008) M. Baumhakel et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The power to TRANSCEND
- (2008) Toni L Ripley et al. LANCET
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
- (2008) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started